ALDX
Aldeyra Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.66
−3.58%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -1.19x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 2.10x
Liquidity & coverage
- Current ratio
- 4.91x
- Quick ratio
- 4.91x
- Cash ratio
- 4.67x
- Interest coverage
- -16.95x
- EBITDA / interest
- -15.05x
- Working capital
- $37.7M
Cash & dividend
- FCF / debt
- -153.67x
- Cash flow / debt
- -153.51x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026